Drug Chatter -- Tracking biopharma stock chatter

Profile for Seattle Genetics, Inc. (SGEN)

« Back to company index

SGEN Chatter Timeline

Stock Ticker for SGEN

Most Active Tweeters for SGEN

UserTweets
@WKRBNews 7
@TheMarketsDaily 7
@dakotafinancial 6
@dailypoliticaln 4
@intercooleronli 4

Recent Tweets for SGEN

midetimes @midetimes
Seattle Genetics, Inc. $SGEN Position Raised by Meeder Asset Management Inc. https://t.co/gOD19l0ror
July 24th 2017, 10:07am
TheMarketsDaily @TheMarketsDaily
Seattle Genetics, Inc. $SGEN Shares Bought by Meeder Asset Management Inc. https://t.co/ZiYA4co9LT
July 24th 2017, 10:07am
biotech_sector @biotech_sector
#SeattleGenetics Announces Clinical Collaboration To Expand The Therapeutic Evaluation Of S... Read more: https://t.co/lILNaQUuFv $SGEN
July 24th 2017, 10:07am
Briefingcom @Briefingcom
$SGEN: Seattle Genetics announces clinical collaboration agreement with Roche (RHHBY) for the evaluation of its... https://t.co/yexlNyj8Lh
July 24th 2017, 10:07am
biotech_sector @biotech_sector
#SeattleGenetics Announces Clinical Collaboration to Expand the Therapeutic Evaluation of S... Read more: https://t.co/ed6LqDeKkl $SGEN
July 24th 2017, 9:07am
kuritzmike @kuritzmike
RT @BioStocks: $SGEN & Genentech Collaboration to Expand the Therapeutic Evaluation of SGN-LIV1A in Triple Negative Breast Cancer https://t…
July 24th 2017, 9:07am
Lin_ling_88 @Lin_ling_88
$SGEN Announces Clinical Collaboration to Expand the Evaluation of SGN-LIV1A in Triple Negative Breast Cancer $RHHBY https://t.co/ypYyK1An4t
July 24th 2017, 9:07am
newswithvalue @newswithvalue
$SGEN: Seattle Genetics teams up with Roche’s Genentech to evaluate ADC …: https://t.co/Q5ktR9h3bV
July 24th 2017, 9:07am
SEEKINGALPHA_FS @SEEKINGALPHA_FS
Seattle Genetics teams up with Roche's Genentech to evaluate ADC/Tecentriq combo in diffi... https://t.co/EBl6mBnsNx #premarket $SGEN $RHHBY
July 24th 2017, 8:07am
MarketCurrents @MarketCurrents
Seattle Genetics teams up with Roche's Genentech to evaluate ADC/Tecentriq combo in diffi... https://t.co/v7rOzAkGZe #premarket $SGEN $RHHBY
July 24th 2017, 8:07am
tickerws @tickerws
$SGEN, Genentech collaborate for evaluation of SGN-LIV1A https://t.co/0ocGueLenh
July 24th 2017, 8:07am
YoungChris27040 @YoungChris27040
RT @princetongb: $SGEN Genetics Announces $RHHBY Clinical Collaboration 2 Expand the Tx Evaluation of SGN-LIV1A in Triple Negative BC https…
July 24th 2017, 8:07am
biotech_sector @biotech_sector
#SeattleGenetics Announces Clinical Collaboration to Expand the Therapeutic Evaluation of S... Read more: https://t.co/D9diSRMjay $SGEN
July 24th 2017, 8:07am
BioStocks @BioStocks
$SGEN & Genentech Collaboration to Expand the Therapeutic Evaluation of SGN-LIV1A in Triple Negative Breast Cancer https://t.co/5k2TE1aiz2
July 24th 2017, 8:07am
princetongb @princetongb
$SGEN Genetics Announces $RHHBY Clinical Collaboration 2 Expand the Tx Evaluation of SGN-LIV1A in Triple Negative B… https://t.co/NxuZOQWvdb
July 24th 2017, 8:07am
stockboardinc @stockboardinc
$SGEN Seattle Genetics Announces Clinical Collaboration to Expand the Therapeutic Evaluation of SGN-LIV1A ... - https://t.co/SEBqkhGbhd
July 24th 2017, 8:07am
stocknewsdotcom @stocknewsdotcom
$SGEN Announces clinical collaboration agreement with Roche for the evaluation of its SGN-LIV1A in combination wit… https://t.co/BK5vtMFYda
July 24th 2017, 8:07am
ProVesting @ProVesting
$SGEN: Seattle Genetics Announces Clinical Collaboration to Expand the …: https://t.co/Dw4YPDYqfV
July 24th 2017, 8:07am
Allstocknews @Allstocknews
$SGEN Seattle Genetics Announces Clinical Collaboration to Expand the Therapeutic Evaluation of SGN-LIV1A in From our Stock News Alerts App
July 24th 2017, 8:07am
BareBullTrading @BareBullTrading
$SGEN another one to watch after the inside week could be setting up over the next couple weeks $IBB https://t.co/68HgPRJNgt
July 22nd 2017, 12:07pm
SleekMoneycom @SleekMoneycom
Seattle Genetics, Inc. $SGEN Stake Decreased by JPMorgan Chase & Co. https://t.co/5JGbuv6hPW
July 22nd 2017, 8:07am
TheMarketsDaily @TheMarketsDaily
Assenagon Asset Management S.A. Has $395,000 Position in Seattle Genetics, Inc. $SGEN https://t.co/WsBQaj8HU6
July 21st 2017, 1:07pm
dakotafinancial @dakotafinancial
Xact Kapitalforvaltning AB Sells 553 Shares of Seattle Genetics, Inc. $SGEN https://t.co/R60naxV50i
July 21st 2017, 11:07am
storminvestor @storminvestor
Xact Kapitalforvaltning AB Reduces Stake in Seattle Genetics, Inc. $SGEN https://t.co/Tu1gIhA5BC
July 21st 2017, 10:07am
MarginHunt @MarginHunt
These cashflow models imply Seattle Genetics, Inc. $SGEN has 10% upside before earnings next Thursday… https://t.co/XOviPXmaji
July 21st 2017, 6:07am
dakotafinancial @dakotafinancial
Seattle Genetics, Inc. $SGEN Stake Reduced by Capital Impact Advisors LLC https://t.co/uDcSIAq2n3
July 20th 2017, 2:07pm
emq_news @emq_news
$107.20 Million in Sales Expected for Seattle Genetics, Inc. $SGEN This Quarter https://t.co/TMRVHtqqHk
July 19th 2017, 5:07pm
intercooleronli @intercooleronli
$107.20 Million in Sales Expected for Seattle Genetics, Inc. $SGEN This Quarter https://t.co/9Cb84VoxRs
July 19th 2017, 4:07pm
TickerReport @TickerReport
$107.20 Million in Sales Expected for Seattle Genetics, Inc. $SGEN This Quarter https://t.co/lcZM0CnA5Y
July 19th 2017, 4:07pm
TickerReport @TickerReport
$107.20 Million in Sales Expected for Seattle Genetics, Inc. $SGEN This Quarter https://t.co/9qJN88DhTo
July 19th 2017, 4:07pm
WKRBNews @WKRBNews
$107.20 Million in Sales Expected for Seattle Genetics, Inc. $SGEN This Quarter https://t.co/rKhTmACJXA
July 19th 2017, 4:07pm
dakotafinancial @dakotafinancial
Seattle Genetics, Inc. to Post Q3 2017 Earnings of -$0.47 Per Share, SunTrust Banks Forecasts $SGEN https://t.co/RspViP1J3v
July 19th 2017, 12:07pm
FinInvTr @FinInvTr
Seattle Genetics Part Of Market's Top Large/Mid Cap Fund https://t.co/96bvj3TodH $SGEN
July 19th 2017, 11:07am
TheMarketsDaily @TheMarketsDaily
SunTrust Banks Comments on Seattle Genetics, Inc.’s Q3 2017 Earnings $SGEN https://t.co/DUuFJ1ZEbw
July 18th 2017, 2:07pm
WKRBNews @WKRBNews
SunTrust Banks Comments on Seattle Genetics, Inc.’s Q3 2017 Earnings $SGEN https://t.co/7rQdn57ke4
July 18th 2017, 7:07am
WKRBNews @WKRBNews
SunTrust Banks Comments on Seattle Genetics, Inc.’s Q3 2017 Earnings $SGEN https://t.co/eQBbLtnbgD
July 18th 2017, 7:07am
midetimes @midetimes
Seattle Genetics, Inc. $SGEN Shares Bought by PNC Financial Services Group Inc. https://t.co/2C4Z2aDoC8
July 18th 2017, 5:07am
dailypoliticaln @dailypoliticaln
Seattle Genetics, Inc. $SGEN Shares Bought by PNC Financial Services Group Inc. https://t.co/hpj0GZ3Yi7
July 18th 2017, 5:07am
dailypoliticaln @dailypoliticaln
Seattle Genetics, Inc. $SGEN Receives $62.00 Consensus PT from Brokerages https://t.co/qPggrykWU1
July 17th 2017, 11:07pm
TheMarketsDaily @TheMarketsDaily
Seattle Genetics, Inc. $SGEN Receives $62.00 Consensus PT from Brokerages https://t.co/BytRM8b9Nm
July 17th 2017, 11:07pm
midetimes @midetimes
Seattle Genetics, Inc. $SGEN Receives $62.00 Consensus PT from Brokerages https://t.co/L1CGdno4Ie
July 17th 2017, 11:07pm
intercooleronli @intercooleronli
Seattle Genetics $SGEN – Investment Analysts’ Recent Ratings Changes https://t.co/j2jiB0Q1jP
July 17th 2017, 7:07pm
TheMarketsDaily @TheMarketsDaily
Analysts Expect Seattle Genetics, Inc. $SGEN to Announce -$0.43 EPS https://t.co/EealQqTPMy
July 17th 2017, 2:07pm
WKRBNews @WKRBNews
Analysts Expect Seattle Genetics, Inc. $SGEN to Announce -$0.43 EPS https://t.co/fLJBWqqicj
July 17th 2017, 9:07am
WKRBNews @WKRBNews
Analysts Expect Seattle Genetics, Inc. $SGEN to Announce -$0.43 EPS https://t.co/DASHfALKZR
July 17th 2017, 9:07am
intercooleronli @intercooleronli
Research Analysts Set Expectations for Seattle Genetics, Inc.’s Q3 2017 Earnings $SGEN https://t.co/UI4A4ECFA5
July 17th 2017, 8:07am
SPNewsAnalysis @SPNewsAnalysis
Research Analysts Set Expectations for Seattle Genetics, Inc.’s Q3 2017 Earnings $SGEN https://t.co/cnkclgg09L
July 17th 2017, 7:07am
storminvestor @storminvestor
Research Analysts Set Expectations for Seattle Genetics, Inc.’s Q3 2017 Earnings $SGEN https://t.co/DCa71BrTHd
July 17th 2017, 7:07am
dailypoliticaln @dailypoliticaln
Research Analysts Set Expectations for Seattle Genetics, Inc.’s Q3 2017 Earnings $SGEN https://t.co/A6hyTR5OBl
July 17th 2017, 3:07am
midetimes @midetimes
Research Analysts Set Expectations for Seattle Genetics, Inc.’s Q3 2017 Earnings $SGEN https://t.co/SJZhwV6WzG
July 17th 2017, 3:07am

Contact © thinkBiotech LLC 2004 - 2017. All rights reserved.